These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 32849451)
21. Risk factors for Clostridioides difficile infection and colonization among patients admitted to an intensive care unit in Shanghai, China. Cui Y; Dong D; Zhang L; Wang D; Jiang C; Ni Q; Wang C; Mao E; Peng Y BMC Infect Dis; 2019 Nov; 19(1):961. PubMed ID: 31711425 [TBL] [Abstract][Full Text] [Related]
22. Administration of Bifidobacterium breve Decreases the Production of TNF-α in Children with Celiac Disease. Klemenak M; Dolinšek J; Langerholc T; Di Gioia D; Mičetić-Turk D Dig Dis Sci; 2015 Nov; 60(11):3386-92. PubMed ID: 26134988 [TBL] [Abstract][Full Text] [Related]
23. Prebiotic preferences of human lactobacilli strains in co-culture with bifidobacteria and antimicrobial activity against Clostridium difficile. Ambalam P; Kondepudi KK; Balusupati P; Nilsson I; Wadström T; Ljungh Å J Appl Microbiol; 2015 Dec; 119(6):1672-82. PubMed ID: 26381324 [TBL] [Abstract][Full Text] [Related]
24. Consortium of Probiotics Attenuates Colonization of Li X; Chu Q; Huang Y; Xiao Y; Song L; Zhu S; Kang Y; Lu S; Xu J; Ren Z Front Microbiol; 2019; 10():2871. PubMed ID: 31921049 [No Abstract] [Full Text] [Related]
25. Global transcriptional landscape and promoter mapping of the gut commensal Bifidobacterium breve UCC2003. Bottacini F; Zomer A; Milani C; Ferrario C; Lugli GA; Egan M; Ventura M; van Sinderen D BMC Genomics; 2017 Dec; 18(1):991. PubMed ID: 29281966 [TBL] [Abstract][Full Text] [Related]
26. Genome-Wide Transcription Start Site Mapping and Promoter Assignments to a Sigma Factor in the Human Enteropathogen Soutourina O; Dubois T; Monot M; Shelyakin PV; Saujet L; Boudry P; Gelfand MS; Dupuy B; Martin-Verstraete I Front Microbiol; 2020; 11():1939. PubMed ID: 32903654 [TBL] [Abstract][Full Text] [Related]
27. Zhu D; Sorg JA; Sun X Front Cell Infect Microbiol; 2018; 8():29. PubMed ID: 29473021 [No Abstract] [Full Text] [Related]
28. In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains. Schoster A; Kokotovic B; Permin A; Pedersen PD; Dal Bello F; Guardabassi L Anaerobe; 2013 Apr; 20():36-41. PubMed ID: 23471038 [TBL] [Abstract][Full Text] [Related]
30. Molecular analysis and genotyping of pathogenicity locus in Clostridioides difficile strains isolated from patients in Tehran hospitals during the years 2007-2010. Azimirad M; Azizi O; Alebouyeh M; Aslani MM; Mousavi SF; Zali MR Infect Genet Evol; 2019 Jul; 71():205-210. PubMed ID: 30902742 [TBL] [Abstract][Full Text] [Related]
31. The Bacterial Gut Microbiota of Adult Patients Infected, Colonized or Noncolonized by Crobach MJT; Ducarmon QR; Terveer EM; Harmanus C; Sanders IMJG; Verduin KM; Kuijper EJ; Zwittink RD Microorganisms; 2020 May; 8(5):. PubMed ID: 32384826 [No Abstract] [Full Text] [Related]
32. Mechanistic Study of Utilization of Water-Insoluble Saccharomyces cerevisiae Glucans by Bifidobacterium breve Strain JCM1192. Keung HY; Li TK; Sham LT; Cheung MK; Cheung PCK; Kwan HS Appl Environ Microbiol; 2017 Apr; 83(7):. PubMed ID: 28115383 [TBL] [Abstract][Full Text] [Related]
33. Protective Effects of Bifidobacterial Strains Against Toxigenic Wei Y; Yang F; Wu Q; Gao J; Liu W; Liu C; Guo X; Suwal S; Kou Y; Zhang B; Wang Y; Zheng K; Tang R Front Microbiol; 2018; 9():888. PubMed ID: 29867801 [TBL] [Abstract][Full Text] [Related]
34. Domestic canines do not display evidence of gut microbial dysbiosis in the presence of Clostridioides (Clostridium) difficile, despite cellular susceptibility to its toxins. Stone NE; Nunnally AE; Jimenez V; Cope EK; Sahl JW; Sheridan K; Hornstra HM; Vinocur J; Settles EW; Headley KC; Williamson CHD; Rideout JR; Bolyen E; Caporaso JG; Terriquez J; Monroy FP; Busch JD; Keim P; Wagner DM Anaerobe; 2019 Aug; 58():53-72. PubMed ID: 30946985 [TBL] [Abstract][Full Text] [Related]
35. Beneficial Effect of Yun B; Song M; Park DJ; Oh S Korean J Food Sci Anim Resour; 2017; 37(3):368-375. PubMed ID: 28747822 [No Abstract] [Full Text] [Related]
36. Immunomodulatory effect of Ren J; Zhao Y; Huang S; Lv D; Yang F; Lou L; Zheng Y; Zhang J; Liu S; Zhang N; Bachert C Exp Ther Med; 2018 Nov; 16(5):3996-4004. PubMed ID: 30344677 [TBL] [Abstract][Full Text] [Related]
37. Effective Dosage of Oral Vancomycin in Treatment for Initial Episode of Chiu CY; Sarwal A; Feinstein A; Hennessey K Antibiotics (Basel); 2019 Oct; 8(4):. PubMed ID: 31581576 [No Abstract] [Full Text] [Related]
38. Modified Mouse Model of Clostridioides difficile Infection as a Platform for Probiotic Efficacy Studies. De Wolfe TJ; Kates AE; Barko L; Darien BJ; Safdar N Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 30988143 [TBL] [Abstract][Full Text] [Related]
39. Prevalence and Strain Characterization of Seugendo M; Janssen I; Lang V; Hasibuan I; Bohne W; Cooper P; Daniel R; Gunka K; Kusumawati RL; Mshana SE; von Müller L; Okamo B; Ortlepp JR; Overmann J; Riedel T; Rupnik M; Zimmermann O; Groß U Front Microbiol; 2018; 9():1843. PubMed ID: 30131799 [No Abstract] [Full Text] [Related]
40. [Probiotics improve obesity-associated dyslipidemia and insulin resistance in high-fat diet-fed rats]. Yu RQ; Yuan JL; Ma LY; Qin QX; Wu XY Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec; 15(12):1123-7. PubMed ID: 24342213 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]